On October 21, 2025, Paine Schwartz Partners–backed HGS BioScience announced it had acquired NutriAg Ltd., a Toronto-based innovator in bionutritional technologies. The combinations brings together HGS’s strength in humic acid-based products, U.S. market presence, and vertically integrated manufacturing footprint with NutriAg’s bionutritional product portfolio, Canadian market access, and research and development engine. The result is one of the most complete biostimulant and bionutritional platforms in North America.
HGS BioScience is a leading provider in humic and fulvic products.
Osler, Hoskin & Harcourt LLP advised Paine Schwartz Partners and HGS BioScience with a team consisting of Alex Gorka, Rob Valentini, Page MacRae (Corporate), Damian Rigolo, Irmak Aydemir (Employment and Labour), Matthew Ritchie, Carolin Jumaa (Real Estate), Marta Rochkin, Malcolm Peck-McQueen (Financial Services), Jennifer Fairfax, Evan Barz (Environmental), Taylor Cao, Okanga Okanga (Tax), Jonathan Marin, Ann Zhang (Pensions and Benefits), Kelly Moffatt, Justin P’ng (Intellectual Property), Susan Newell and Aya Fahmi (Health).
Key Contact
Partner, Corporate, Toronto
Team
Associate, Corporate, Toronto
Associate, Corporate, Toronto
Partner, Employment and Labour, Toronto
Associate, Employment and Labour, Toronto
Partner, Real Estate, Toronto
Associate, Real Estate, Toronto
Partner, Financial Services, Toronto
Associate, Financial Services, Toronto
Partner, Litigation; Regulatory, Indigenous and Environmental, Toronto
Associate, Disputes, Toronto
Partner, Tax, Toronto
Associate, Tax, Toronto
Partner, Pensions and Benefits, Toronto
Associate, Pensions and Benefits, Toronto
Partner, Commercial, Toronto
Associate, Privacy and Data Management, Toronto
Partner, Health, Toronto
Associate, Health, Toronto
